Korean case marks more quality woes for J&J
This article was originally published in Scrip
Executive Summary
Janssen (Johnson & Johnson) appears confident of resolving the quality control shortcomings that led to the recall of a product in South Korea, but regulatory authorities in the country are nevertheless pushing ahead with legal action against the firm's local subsidiary.